NOTE

🌱 created from: treatment_of_all

ino-vate_all

Kantarjian HM. Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia. The New England Journal of Medicine. Published August 25, 2016. Accessed October 11, 2024. https://www.nejm.org/doi/full/10.1056/NEJMoa1509277